Imagen 1 de 1
Foto genérica
Imagen 1 de 1
Foto genérica
Biopolitics Ser.: Contraceptive Risk : The FDA, Depo-Provera, and the Politics of Experimental Medicine by William Green (2017, Hardcover)
Booksxpress (9186)
95,9% de votos positivos
Precio:
USD144,55
Aproximadamente123,52 EUR
+ USD22,21 de envío
Devoluciones:
30 días para devoluciones. El comprador paga el envío de la devolución..
Estado:
Contraceptive Risk: The FDA, Depo-Provera, and the Politics of Experimental Medicine (Biopolitics) by Green, William [Hardcover]
- ¡Cómpralo ya!Contraceptive Risk: The FDA, Depo-Provera, and the Politics of Experimental M...
Oops! Looks like we're having trouble connecting to our server.
Refresh your browser window to try again.
Acerca de este artículo
Product Identifiers
PublisherNew York University Press
ISBN-101479876992
ISBN-139781479876990
eBay Product ID (ePID)234922285
Product Key Features
Number of Pages336 Pages
LanguageEnglish
Publication NameContraceptive Risk : the Fda, Depo-Provera, and the Politics of Experimental Medicine
SubjectWomen's Health, Public Policy / General, Administrative Law & Regulatory Practice
Publication Year2017
TypeTextbook
AuthorWilliam Green
Subject AreaLaw, Political Science, Health & Fitness
SeriesBiopolitics Ser.
FormatHardcover
Dimensions
Item Height1.1 in
Item Weight20.5 Oz
Item Length9.3 in
Item Width6.2 in
Additional Product Features
Intended AudienceScholarly & Professional
LCCN2017-003468
Dewey Edition23
ReviewsSeldom has a study connected the micro with the macro, the personal with the legal, the individual with the structural in the manner and depth present in Contraceptive Risk. Using three concurrent and overlapping stories, Green explores in dizzying fashion, the politics of contraceptive risk management., By far the most thorough account of the Depo-Provera story to date. Though we may never get clear answers about whether Depo-Provera has done more harm than good over the past few decades, this well-researched history will be of great interest to those in the public health and women and gender studies fields, as well as many women contemplating the use of Depo-Provera themselves., "William Green's fascinating tale of the use and misuse of Depo-Provera highlights the complex and faulty world of 'risk management,' the competing powerful interests at stake in drug approval and use, and the misuse of contraceptive drugs in controlling reproduction and sexual deviance." -Karen L. Baird,co-author of Beyond Reproduction: Women's Health, Activism, and Public Policy, William Greens fascinating tale of the use and misuse of Depo-Provera highlights the complex and faulty world of & risk management, the competing powerful interests at stake in drug approval and use, and the misuse of contraceptive drugs in controlling reproduction and sexual deviance., "By far the most thorough account of the Depo-Provera story to date. Though we may never get clear answers about whether Depo-Provera has done more harm than good over the past few decades, this well-researched history will be of great interest to those in the public health and women and gender studies fields, as well as many women contemplating the use of Depo-Provera themselves."-Judy Norsigian,co-author and co-founder of Our Bodies Ourselves and the Boston Women's Health Book Collective
Series Volume Number12
Dewey Decimal618.18
SynopsisThe story of Depo-Provera joins the national struggle over the drug's FDA approval to the state legal issues raised by its contraceptive and criminal justice uses. Depo-Provera is known as an injectable hormonal birth control method, but few are familiar with its dark and complicated history. Depo-Provera was tested on women since the mid-1960s without their informed consent until it was FDA-approved in 1992, but never FDA-approved as chemical castration for male sex offenders. Contraceptive Risk is William Green's landmark study of Depo-Provera. Based on a fascinating combination of archival materials and interviews, the book is framed as three interconnected stories told by Judith Weisz, who chaired the FDA's Public Board of Inquiry on Depo-Provera, a scientific court; by Anne MacMurdo who brought a products liability suit against Upjohn, the drug's manufacturer, for the deleterious side effects she suffered from the drug's use; and by Roger Gauntlett, an Upjohn heir who, when he was convicted of sexual assault, refused to take a dose of his family's own medicine as a probation condition. Together these three stories of Depo-Provera's convoluted fifty year odyssey call for a paradigm shift in pharmaceutical drug development. Contraceptive Risk is a thoroughly researched and engrossing approach to the scientific, political and institutional forces involved in health law and policy, as well as the multifaceted politics of measuring risk., The story of Depo-Provera joins the national struggle over the drug's FDA approval to the state legal issues raised by its contraceptive and criminal justice uses. Depo-Provera is known as an injectable hormonal birth control method, but few are familiar with its dark and complicated history. Depo-Provera was tested on women since the mid-1960s ......
LC Classification NumberRG136.G67 2017
